XY Capital’s ResMed RMD Stock Holding History

XY Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.17M	Buy	+36,769	New	+$7.62M	6.91%	5
2026 Q1	–	Sell	-20,492	Closed	-$4.94M	–	265
2025 Q4	$4.94M	Buy	+20,492	New	+$5.24M	3.11%	4
2025 Q3	–	Sell	-14,624	Closed	-$3.77M	–	165
2025 Q2	$3.77M	Buy	+14,624	New	+$3.49M	2.6%	12
2024 Q4	–	Sell	-12,111	Closed	-$2.96M	–	216
2024 Q3	$2.96M	Sell	12,111 -11,628	-49%	-$2.6M	1.01%	21
2024 Q2	$4.54M	Buy	+23,739	New	+$4.82M	2.87%	6
2024 Q1	–	Sell	-74,580	Closed	-$12.8M	–	98
2023 Q4	$12.8M	Sell	74,580 -16,884	-18%	-$2.59M	7.49%	1
2023 Q3	$13.5M	Buy	91,464 +90,147	+6,845%	+$16.3M	7.76%	1
2023 Q2	$288K	Buy	+1,317	New	+$294K	0.21%	82

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XY Capital's RMD Position: Q2 2026 in Review

XY Capital opened a new position in ResMed (RMD) in Q2 2026: 36,769 shares worth $7.17M. The stake represents 6.91% of the portfolio and ranks #5 among its holdings. This is a return to the name: XY Capital previously reported a position in RMD as recently as Q4 2025.

XY Capital first reported a position in RMD in Q2 2023 and has held it in 8 quarters since. The position peaked at $13.5M in Q3 2023. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

XY Capital held 36,769 shares of ResMed worth $7.17M as of Q2 2026.
ResMed was a new XY Capital position in Q2 2026.
ResMed made up 6.91% of XY Capital's portfolio in Q2 2026, its #5 holding.
XY Capital first reported a position in ResMed in Q2 2023 and has held it in 8 quarters since.
XY Capital's ResMed position peaked at $13.5M in Q3 2023.
888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on XY Capital's 13F filing for Q2 2026, filed 11 Aug 2026.